Aug 11 (Reuters) - Kala Pharmaceuticals Inc KALA.O :
* KALA PHARMACEUTICALS REPORTS SECOND QUARTER 2022 FINANCIAL
RESULTS AND PROVIDES CORPORATE UPDATE
* KALA PHARMACEUTICALS - BASED ON CURRENT PLANS, ANTICIPATES
CASH
RESOURCES AS OF JUNE 30, 2022, WILL ENABLE IT TO FUND ITS
OPERATIONS INTO Q2 OF 2024
* KALA PHARMACEUTICALS INC - FOR QUARTER ENDED JUNE 30,
2022, KALA
REPORTED NET PRODUCT REVENUES OF $2.1 MILLION
* KALA PHARMACEUTICALS INC QTRLY NET LOSS $0.38 PER SHARE
Source text for Eikon: ID:nGNX7xVvrc
Further company coverage: KALA.O